... BRAF V600K mutation had a response to vemurafenib. AEs required dose modification or interruption in 38% of patients who ... similar outcomes. Median OS has not been reached. AEs leading to dose interruptions occurred in 35% of patients in the ...

... dose aripiprazole for bipolar disorder. Key Points: Major AEs The effects between different doses of SGAs in terms of major AEs during ... least low SOE for an outcome of general AEs in studies comparing different doses of SGAs. The doses considered are identified for ...

... Mortality: NR 4) Morbidity: NR 5) Safety: Any AE: Valsartan (any dose): 62.6% Lisinopril (either dose): 58.3% AEs ... rating: Fair Comments: - Numbers screened and eligible NR - AEs not well reported - Details of dose titration and concomitant med use (if any) not ...

... early: 2.5% (2/79) Discontinuation due to AEs during open-label dose titration phase: 12% (12/103) Discontinuation due to AEs during double-blind phase: 2.5% (2/79) ...

... trial suggested risk of harms (withdrawal due to AEs) for high-dose duloxetine (60 mg) versus placebo among children and ...

... have a substantial effect on the assessment of AEs, particularly if dose or cumulative dose effects are suspected. Patient compliance ...

... 2.13) 48 - - 1.4(2.16) 48 AE = adverse event; N = number Table G10 Findings for GAE: Dose comparisons - quetiapine View in own window Outcome Author, ... 1.2 30 2.4(2.07) 31 - - - - AE = adverse event; BMI = body mass index; EPS = ... G12 Findings for GAE: Dose comparisons - ziprasidone View in own window Outcome Author, ...

... Rehabilitation. 2013; 19 (1):25–26. 181. Frampton AE, Eynon CA. High dose methylprednisolone in the immediate management of acute, blunt ...

... explore the safety and efficacy of orally administered AE-941/Neovastat when administered in escalating doses (30, 60, 120, and 240 mL/day). No ... II trials g Various advanced, refractory solid tumors AE-941/ Neovastat (shark) ... survival, higher versus lower doses, patients with stage III/IV non-small cell ...

... did not differ significantly between groups. Subject-reported AEs were more common in the higher-dose colestipol-only group than in the combination group: ...